AstraZeneca Joins Trump's Drug Price Reduction Program
CNBC TelevisionNovember 5, 20252 min11,229 views
14 connections·19 entities in this video→AstraZeneca's Agreement
- 💊 AstraZeneca has become the second drug maker to agree to President Trump's Most Favored Nation drug price program.
- 📍 This announcement follows the groundbreaking of a $4.5 billion plant in Virginia, attended by CMS administrator Dr. Oz.
Context of Drug Price Negotiations
- 🤝 The AstraZeneca deal comes 10 days after a similar agreement with Pfizer, which included lower prices for Medicaid and a $70 billion US investment.
- 🚫 In exchange for the Pfizer deal, the company will not face tariffs for three years.
Administration's Goals and Strategy
- 🎯 CMS administrator Dr. Oz aims to align US drug prices with those paid in Europe, targeting 95% of drugs.
- 🗣️ When asked about GLP1 drugs for weight loss in Medicare, Dr. Oz stated that
Knowledge graph19 entities · 14 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover · drag to explore
19 entities
Chapters1 moments
Key Moments
Transcript8 segments
Full Transcript
Topics10 themes
What’s Discussed
Most Favored Nation drug price programAstraZenecaTrump AdministrationDrug PricesPfizerMedicaidCMS AdministratorDr. OzMedicareIRA price negotiation
Smart Objects19 · 14 links
Companies· 5
Events· 3
People· 3
Products· 2
Concepts· 5
Location· 1